Thierry Burnouf: Platelet-Derived Products as Acellular Biotherapies for Neurological Disorders
Thierry Burnouf, Vice-Dean, Distinguished Professor, Biomedical Engineering at Taipei Medical University, shared a post on LinkedIn about a recent article he and his colleagues co-authored, adding:
“I am pleased to share our new review in Trends in Molecular Medicine:
‘Platelet-derived and platelet secretome biotherapies for precision neuromedicine’.
In this article, we discuss how platelet-derived products, including platelet lysates, secretome fractions, and extracellular vesicles, may offer a new platform for the development of acellular biotherapies for neurological disorders.
Their multimodal composition may help address complex disease mechanisms involving neuroinflammation, oxidative stress, ferroptosis, synaptic dysfunction, and impaired neurogenesis.
The review also discusses how omics-guided fractionation and pre-clinical data, biomarker development, and imaging approaches may help move these products toward more precise and standardized clinical applications.
Many thanks to all co-authors (MingLi Chou, David Blum, Fabrice Cognasse, Grégory Kuchcinski, David Devos, Thierry Burnouf) involved in this work, and in the pre-clinical and clinical development of platelet biotherapies for the treatment of brain diseases.”
Title: Platelet-derived and platelet secretome biotherapies for precision neuromedicine
Authors: Ming-Li Chou, David Blum, Fabrice Cognasse, Grégory Kuchcinski, David Devos, Thierry Burnouf
Read the Full Article on Trends in Molecular Medicine

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 15, 2026, 23:44Pablo César Spada: Prevention of Venous Thromboembolism After Total Hip or Knee Replacement
-
Nov 15, 2026, 23:30Eshal Amir: Factor XI Inhibitors in AFib and Aortic Mortality Trends
-
Nov 15, 2026, 23:19Hamza Bashir: Adding Endovascular Therapy to Anticoagulation Cuts Moderate-to-Severe PTS in Half
-
Nov 15, 2026, 23:06Lanre Tunji-Ajayi: 2 Days of Deliberative Dialogue Hosted by the Network of Rare Blood Disorder Organizations
-
Nov 15, 2026, 23:00Fanny Delettre: Looking Back at Volunteer Blood Donor Friends Day
-
Nov 15, 2026, 20:56Victoria Adedoyin Adisa-Thomas: What I Learned About SCD During My Genetic Counselling Rotation
-
Nov 15, 2026, 20:55Martin Holst Lange: One Step Closer to a Potential New Treatment for Sickle Cell Disease
-
Nov 15, 2026, 20:53Bontha Babu: Health-Related Quality of Life Among Adults with Sickle Cell Disease in India
-
Nov 15, 2026, 20:52Miguel Ángel Herrera Rojas: A First-Line ITP Approach Presented at ASH in 2013 Now Reflected in the 2026 Guidelines